Gainers
-
Cleantech Solutions International Inc (NASDAQ: CLNT) rose 32.1 percent to $4.32 in pre-market trading as YSK 1860 Co reported
a 29.4 percent stake in Cleantech after the close on Monday.
-
Recro Pharma Inc (NASDAQ: REPH) rose 13.2 percent
to $8.50 in pre-market trading after the company reported successful top-line results from Phase III safety study of IV
Meloxicam.
-
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares
rose 12.7 percent to $10.94 in pre-market trading after the company posted a profit in its first quarter, versus a year-ago
loss. The company also raised its FY17 adjusted EBITDA outlook.
-
Camtek LTD. (NASDAQ: CAMT) shares rose 10.7
percent to $4.45 in pre-market trading after reporting upbeat quarterly results.
-
Fabrinet (NYSE: FN) rose 10.6 percent to $37.60 in
pre-market trading. Fabrinet posted downbeat Q3 earnings, but revenue exceeded estimates.
-
Nova Measuring Instruments Ltd. (NASDAQ: NVMI)
shares rose 10 percent to $21.15 in pre-market trading. Nova Measuring Instruments reported Q1 profit of $13.4 million on
revenue of $54.4 million.
-
Soligenix, Inc. (NASDAQ: SNGX) rose 9.8 percent
to $2.80 in pre-market trading after dropping 7.61 percent on Monday.
-
Office Depot Inc (NASDAQ: ODP) shares rose 7.4
percent to $5.49 in pre-market trading after the company reported better-than-expected earnings for its first quarter.
-
Gener8 Maritime Inc (NYSE: GNRT) rose 6.6 percent
to $5.20 in pre-market trading after the company reported strong quarterly results.
-
Daqo New Energy Corp (NYSE: DQ) rose 6.5 percent to
$21.00 in pre-market trading. Daqo New Energy reported Q1 earnings of $22.9 million on revenue of $83.8 million.
-
Check Cap Ltd (NASDAQ: CHEK) rose 6.4 percent to
$2.10 in pre-market trading. Check-Cap reported Q1 adjusted net loss of $2.4 million.
-
Endo International plc (NASDAQ: ENDP) shares rose
5.8 percent to $11.48 in pre-market trading after reporting strong quarterly profit.
-
Marriott International Inc (NASDAQ: MAR) shares
rose 5 percent to $101.16 in pre-market trading after the company posted stronger-than-expected earnings for its first quarter.
-
Five9 Inc (NASDAQ: FIVN) rose 4.7 percent to
$21.50 in pre-market trading after slipping 0.19 percent on Monday.
-
Pandora Media Inc (NYSE: P) rose 3.9 percent to $10.80
in pre-market trading. Pandora posted a narrower-than-expected loss for its first quarter, but issued a weak sales forecast for
the current quarter. Pandora announced a $150 million investment by KKR and disclosed that the company is exploring strategic
alternatives, including a sale.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Hertz Global Holdings, Inc (NYSE: HTZ) shares fell
16.8 percent to $12.40 in the pre-market trading session as the company reported a wider-than-expected loss for its first
quarter.
-
Nevro Corp (NASDAQ: NVRO) fell around 12.3
percent to $75.70 in pre-market trading as the company posted a larger-than-expected quarterly loss. Riley downgraded Nevro
from Buy to Neutral.
-
Allot Communications Ltd (NASDAQ: ALLT) shares
fell 9.6 percent to $4.44 in pre-market trading after the company posted a wider-than-expected Q1 loss.
-
Cytokinetics, Inc. (NASDAQ: CYTK) fell 9.3
percent to $14.20 in pre-market trading. Cytokinetics priced its 5.26 million share offering at $14.25 per share.
-
Inpixon (NASDAQ: INPX) fell 7.9 percent to $4.09
in pre-market trading after surging 148.04 percent on Monday.
-
Meet Group Inc (NASDAQ: MEET) shares fell 6.5
percent to $5.90 in pre-market trading. Meet Group reported adjusted earnings of $0.07 per share on revenue of $20.1 million.
-
Armada Hoffler Properties Inc (NYSE: AHH) fell 5.2
percent to $13.06 in pre-market trading. Armada Hoffler Properties priced 6 million shares at $13 per share.
-
Preferred Apartment Communities Inc. (NYSE: APTS)
fell 4.9 percent to $15.10 in pre-market trading. Preferred Apartment Communities reported a proposed public offering of 2.75
million shares of common stock.
-
Cytosorbents Corp (NASDAQ: CTSO) fell 4.3 percent
to $4.50 in pre-market trading. CytoSorbents reported a Q1 loss of $0.05 per share on revenue of $2.59 million.
-
Achaogen Inc (NASDAQ: AKAO) fell 4.2 percent to
$22.50 in pre-market trading. Achaogen reported a Q1 loss of $33.3 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.